Article
EFPIA Disclosure Code Offers Benefits as Well as Challenges
In this month’s PharmaTimes, Veeva’s life sciences compliance and data expert, Guillaume Roussel explains implications of the new EFPIA reporting requirements on public trust and marketing spend.